Concepedia

Amy R. Barker

AR

4

Publications

209

Citations

4

H-Index

2011

Active since

Affiliations

Eli Lilly (United States)(Current)

Bayer (Germany)

PHV Dialysezentrum

United States Food and Drug Administration

National Institute of Health Sciences

Amy R. Barker is an author at Eli Lilly (United States) specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

2011–2022

4

Publications

4

FIP/AAPS Joint Workshop Report: Dissolution/In Vitro Release Testing of Novel/Special Dosage Forms

Cynthia K. Brown, Horst Dieter Friedel, Amy R. Barker et al. · AAPS PharmSciTech · 2011 · 117 citations

, , +4

FIP Guidelines for Dissolution Testing of Solid Oral Products

Horst Dieter Friedel, Cynthia K. Brown, Amy R. Barker et al. · Journal of Pharmaceutical Sciences · 2018 · 56 citations

, ,

Biorelevant In Vitro Performance Testing of Orally Administered Dosage Forms—Workshop Report

Christos Reppas, Horst-Dieter Friedel, Amy R. Barker et al. · Pharmaceutical Research · 2014 · 21 citations

, , +9

Current Approaches for Dissolution Similarity Assessment, Requirements, and Global Expectations

Andreas Abend, Limin Zhang, Emilija Fredro-Kumbaradzi et al. · The AAPS Journal · 2022 · 15 citations

, , +3

Rows per page

1–4 of 4